Developing new medicines for people in need
At Xenon, we are forging a new path for people with neurological and psychiatric conditions, beginning with our late-stage investigational candidate, azetukalner, currently in development for epilepsy and depression.
Leadership in ion channel science
We are leveraging our heritage in human genetics, deep understanding of ion channel biology, and expertise in novel chemistries to enable potent, selective ion channel targeting in the central and peripheral nervous systems.
More than a leading neuroscience company
Our team is deeply focused on doing the best work of their lives—because they know it matters, and the impact will be real for patients.
Patients and families at the core of our mission
We are dedicated to listening and learning from people impacted by neurological and psychiatric disorders and making sure they always feel valued and supported—because their experience is at the heart of everything we do.
